Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-18-000119
Filing Date
2018-05-10
Accepted
2018-05-10 12:53:47
Documents
23
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skin0503form10q.htm 10-Q 111458
2 EXHIBIT 31.1 skin0503form10qexh31_1.htm EX-31.1 8421
3 EXHIBIT 31.2 skin0503form10qexh31_2.htm EX-31.2 8440
4 EXHIBIT 32.1 skin0503form10qexh32_1.htm EX-32.1 4269
  Complete submission text file 0001554795-18-000119.txt   489309

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20180331.xml EX-101.INS 20861
6 XBRL SCHEMA FILE skin-20180331.xsd EX-101.SCH 6490
7 XBRL CALCULATION FILE skin-20180331_cal.xml EX-101.CAL 15388
8 XBRL DEFINITION FILE skin-20180331_def.xml EX-101.DEF 4275
9 XBRL LABEL FILE skin-20180331_lab.xml EX-101.LAB 56232
10 XBRL PRESENTATION FILE skin-20180331_pre.xml EX-101.PRE 38326
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

EIN.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 18821485
SIC: 6770 Blank Checks